Bruce Cozadd files Form 144 to sell shares — Jazz Pharmaceuticals (NASDAQ: JAZZ)

Rhea-AI Filing Summary

Jazz Pharmaceuticals submitted a Section 144 notice listing planned sales of Common Stock by an affiliate and recent dispositions. The filing lists three recent sales by Bruce Cozadd of 6,000 shares on 04/01/2026, 6,000 shares on 05/01/2026, and 6,000 shares on 06/01/2026. The filing also records previously issued stock options dated 02/26/2018 (1,335), 03/05/2018 (4,362), and 02/28/2019 (303).

Insights

Equity Capital Markets Analyst

Form 144 lists proposed sales and recent insider dispositions totaling 18,000 shares.

The excerpt shows three reported dispositions by Bruce Cozadd of 6,000 shares each on 04/01/2026, 05/01/2026, and 06/01/2026

These filings are administrative notices required to register brokered resale of restricted or control securities. Cash‑flow treatment and whether further sales are planned are not specified in the excerpt.

Corporate Governance Specialist

Section 144 filings document affiliate resale mechanics, not company actions.

Entries list security types (stock options and common shares) and per‑grant share counts with grant dates. The listed stock options (1,335; 4,362; 303) appear as source instruments but the excerpt does not connect them to a specific resale method.

Timing and proceeds allocation are not stated; subsequent SEC filings or broker disclosures may clarify execution details.

Key Figures

Recent dispositions by Bruce Cozadd: 6,000 shares Recent dispositions by Bruce Cozadd: 6,000 shares Recent dispositions by Bruce Cozadd: 6,000 shares +3 more

6 metrics

Recent dispositions by Bruce Cozadd 6,000 shares 04/01/2026 reported sale

Recent dispositions by Bruce Cozadd 6,000 shares 05/01/2026 reported sale

Recent dispositions by Bruce Cozadd 6,000 shares 06/01/2026 reported sale

Stock option grant 1,335 grant dated 02/26/2018

Stock option grant 4,362 grant dated 03/05/2018

Stock option grant 303 grant dated 02/28/2019

Key Terms

Form 144, Stock Option, Section 144 notice

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option financial

"Stock Option | Jazz Pharmaceuticals PLC | 1335 | 02/26/2018"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Section 144 notice regulatory

"144: Securities To Be Sold"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/01/2026 - 03:55 PM Accepted by SEC EDGAR 07/01/2026 - 03:55 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3075A Hansen Way 1st Floor Palo Alto CA 94304	6000	1442820	62742820	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2018	Stock Option	Jazz Pharmaceuticals PLC			1335	02/26/2018	Cash
Common	03/05/2018	Stock Option	Jazz Pharmaceuticals PLC			4362	03/05/2018	Cash
Common	02/28/2019	Stock Option	Jazz Pharmaceuticals PLC			303	02/28/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	06/01/2026	6000	1410720
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	05/01/2026	6000	1213980
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	04/01/2026	6000	1143010.3

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Jazz Pharmaceuticals' Form 144 disclose about insider sales?

The filing lists three recent dispositions by Bruce Cozadd of 6,000 shares each on 04/01/2026, 05/01/2026, and 06/01/2026. It is a notice of proposed resale under Section 144 rather than a company sale announcement.

Does the Form 144 show how much cash Jazz (JAZZ) received from the sales?

The excerpt does not state who received cash or the allocation of proceeds. It records share counts and numeric values adjacent to each sale line but does not explicitly label proceeds recipients or uses.

Are the securities being sold from option exercises or existing holdings?

The filing lists stock option grants dated 02/26/2018 (1,335), 03/05/2018 (4,362), and 02/28/2019 (303). The excerpt does not explicitly link these grants to the reported sales.

Who is the reporting person on this Form 144 for JAZZ?

The Form identifies Bruce Cozadd as the reporting person, with an address shown in Dublin. The filing shows his recent dispositions of 6,000 shares on three separate dates in 2026.